Browsing Tag
Parse Biosciences
4 posts
Qiagen (NYSE: QGEN) at a crossroads ahead of new CEO and Q1 2026 results
Qiagen (NYSE: QGEN) retail investor roadmap: strategic review, CEO search, 2026 product pipeline and what the May earnings call means for shareholders.
GigaLab by Parse Biosciences: Transforming cell sequencing for drug discovery and AI
Parse Biosciences, a pioneer in single cell sequencing, has announced its groundbreaking GigaLab—a transformative lab designed to upscale…
Parse Biosciences secures $50m in Series C for single cell sequencing
Parse Biosciences has announced a significant milestone in their funding journey, securing a total of $50 million through…
Parse Biosciences bolsters single cell portfolio with CRISPR Detect
Parse Biosciences, a provider of accessible and scalable single cell sequencing solutions, has announced the launch of CRISPR…